drugset / Trial / NCT00002684

Combination Chemotherapy in Patients With Advanced Urinary Tract Cancer

NCT00002684 ↗

Phase 2 Completed 40 enrolled Memorial Sloan Kettering Cancer Center
Treatment

Summary

RATIONALE: Drugs used in chemotherapy, such as cisplatin, ifosfamide, and paclitaxel, use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug and giving drugs in different ways may kill more tumor cells. PURPOSE: This phase II trial is studying how well combination chemotherapy works in treating patients with metastatic urinary tract cancer that cannot be treated with surgery.

Timeline

Start
1995-05
Primary completion
2007-10
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Cisplatin Other / unclassified — Intravenous
Subject Ifosfamide Small molecule — Intravenous
Subject Paclitaxel Small molecule — Intravenous